Press release
Erectile Dysfunction Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players
QY Research released a latest market research report on the Global Erectile Dysfunction market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.For More Information About This Report, Please Enter:
https://us.qyresearch.com/reports/348289/erectile-dysfunction
Summary
Market Analysis and Insights: Global Erectile Dysfunction Market
Due to patent expiration of major brands, the global Erectile Dysfunction market size is estimated to be worth US$ 4.86 billion in 2021 and is forecast to a readjusted size of US$ 8.1 billion by 2028 with a CAGR of 7.04% during the review period.
Global Erectile Dysfunction Scope and Market Size
Erectile Dysfunction market is segmented by players, region (country), by type, and by application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application and forecast for the period 2017-2028.
By Company
General Electric
PTC
Siemens
Dassault Systèmes
IBM Corporation
ANSYS
Microsoft Corporation
Oracle CorporationGlobal Erectile Dysfunction Scope and Segment
Erectile Dysfunction market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type, and by Application for the period 2017-2028.
By Company
Eli Lilly
Pfizer
Bayer
BaiYunShan General Factory
S.K. Chemicals
Teva Pharma
Dong-A ST
Petros Pharmaceuticals
Seoul Pharma
Yabang Pharmacy
Segment by Type
Sildenafil
Tadalafil
Others
Segment by Application
Hospital Pharmacies
Private Clinics
Retail Pharmacies
E-Commerce (B2B)
E-Commerce (B2C)
The Goal of the Report
1.To study and analyze the global Erectile Dysfunction consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
2.To understand the structure of Erectile Dysfunction market by identifying its various subsegments.
3.Focuses on the key global Erectile Dysfunction manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
4.To analyze the Erectile Dysfunction with respect to individual growth trends, prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
6.To project the consumption of Erectile Dysfunction submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Target Audience
> Erectile Dysfunction companies
> Research organizations
> Government Organizations
> Research/Consultancy firms
Table of Contents
1 STUDY COVERAGE 1
1.1 Erectile Dysfunction Product Introduction 1
1.2 Market by Type 1
1.2.1 Global Erectile Dysfunction Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1
1.2.2 Sildenafil 3
1.2.3 Tadalafil 4
1.2.4 Others 5
1.3 Market by Application 6
1.3.1 Global Erectile Dysfunction Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 6
1.3.2 Hospital Pharmacies 8
1.3.3 Private Clinics 9
1.3.4 Retail Pharmacies 9
1.3.5 E-Commerce (B2B) 10
1.3.6 E-Commerce (B2C) 10
1.4 Study Objectives 10
1.5 Years Considered 11
2 EXECUTIVE SUMMARY 12
2.1 Global Erectile Dysfunction Sales Estimates and Forecasts 2017-2028 12
2.2 Global Erectile Dysfunction Revenue Estimates and Forecasts 2017-2028 12
2.3 Global Erectile Dysfunction Revenue by Region: 2017 VS 2021 VS 2028 14
2.4 Global Erectile Dysfunction Sales by Region 15
2.4.1 Global Erectile Dysfunction Sales by Region (2017-2022) 15
2.4.2 Global Sales Erectile Dysfunction by Region (2023-2028) 16
2.5 Global Erectile Dysfunction Revenue by Region 17
2.5.1 Global Erectile Dysfunction Revenue by Region (2017-2022) 17
2.5.2 Global Erectile Dysfunction Revenue by Region (2023-2028) 18
2.6 North America 19
2.7 Europe 20
2.8 Asia-Pacific 21
2.9 Latin America 22
2.10 Middle East & Africa 23
3 COMPETITION BY MANUFACTURERS 24
3.1 Global Erectile Dysfunction Sales by Manufacturers 24
3.1.1 Global Erectile Dysfunction Sales by Manufacturers (2017-2022) 24
3.1.2 Global Erectile Dysfunction Sales Market Share by Manufacturers (2017-2022) 25
3.1.3 Global Top 3 and Top 5 Largest Manufacturers of Erectile Dysfunction in 2021 25
3.2 Global Erectile Dysfunction Revenue by Manufacturers 26
3.2.1 Global Erectile Dysfunction Revenue by Manufacturers (2017-2022) 26
3.2.2 Global Erectile Dysfunction Revenue Market Share by Manufacturers (2017-2022) 27
3.2.3 Global Top 3 and Top 5 Companies by Erectile Dysfunction Revenue in 2021 27
3.3 Global Erectile Dysfunction Sales Price by Manufacturers (2017-2022) 28
3.4 Analysis of Competitive Landscape 29
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 29
3.4.2 Global Erectile Dysfunction Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 30
3.4.3 Global Erectile Dysfunction Manufacturers Geographical Distribution 31
3.5 Mergers & Acquisitions, Expansion Plans 32
4 MARKET SIZE BY TYPE 34
4.1 Global Erectile Dysfunction Sales by Type 34
4.1.1 Global Erectile Dysfunction Historical Sales by Type (2017-2022) 34
4.1.2 Global Erectile Dysfunction Forecasted Sales by Type (2023-2028) 34
4.1.3 Global Erectile Dysfunction Sales Market Share by Type (2017-2028) 34
4.2 Global Erectile Dysfunction Revenue by Type 35
4.2.1 Global Erectile Dysfunction Historical Revenue by Type (2017-2022) 35
4.2.2 Global Erectile Dysfunction Forecasted Revenue by Type (2023-2028) 36
4.2.3 Global Erectile Dysfunction Revenue Market Share by Type (2017-2028) 36
4.3 Global Erectile Dysfunction Price by Type 37
4.3.1 Global Erectile Dysfunction Price by Type (2017-2022) 37
4.3.2 Global Erectile Dysfunction Price Forecast by Type (2023-2028) 37
5 MARKET SIZE BY APPLICATION 38
5.1 Global Erectile Dysfunction Sales by Application 38
5.1.1 Global Erectile Dysfunction Historical Sales by Application (2017-2022) 38
5.1.2 Global Erectile Dysfunction Forecasted Sales by Application (2023-2028) 38
5.1.3 Global Erectile Dysfunction Sales Market Share by Application (2017-2028) 38
5.2 Global Erectile Dysfunction Revenue by Application 40
5.2.1 Global Erectile Dysfunction Historical Revenue by Application (2017-2022) 40
5.2.2 Global Erectile Dysfunction Forecasted Revenue by Application (2023-2028) 40
5.2.3 Global Erectile Dysfunction Revenue Market Share by Application (2017-2028) 40
5.3 Global Erectile Dysfunction Price by Application 41
5.3.1 Global Erectile Dysfunction Price by Application (2017-2022) 41
5.3.2 Global Erectile Dysfunction Price Forecast by Application (2023-2028) 42
6 NORTH AMERICA 43
6.1 North America Erectile Dysfunction Market Size by Type 43
6.1.1 North America Erectile Dysfunction Sales by Type (2017-2028) 43
6.1.2 North America Erectile Dysfunction Revenue by Type (2017-2028) 44
6.2 North America Erectile Dysfunction Market Size by Application 45
6.2.1 North America Erectile Dysfunction Sales by Application (2017-2028) 45
6.2.2 North America Erectile Dysfunction Revenue by Application (2017-2028) 46
6.3 North America Erectile Dysfunction Sales by Country 47
6.3.1 North America Erectile Dysfunction Sales by Country (2017-2028) 47
6.3.2 North America Erectile Dysfunction Revenue by Country (2017-2028) 48
6.3.3 United States 49
6.3.4 Canada 50
7 EUROPE 51
7.1 Europe Erectile Dysfunction Market Size by Type 51
7.1.1 Europe Erectile Dysfunction Sales by Type (2017-2028) 51
7.1.2 Europe Erectile Dysfunction Revenue by Type (2017-2028) 52
7.2 Europe Erectile Dysfunction Market Size by Application 53
7.2.1 Europe Erectile Dysfunction Sales by Application (2017-2028) 53
7.2.2 Europe Erectile Dysfunction Revenue by Application (2017-2028) 54
7.3 Europe Erectile Dysfunction Market Size by Country 55
7.3.1 Europe Erectile Dysfunction Sales by Country (2017-2028) 55
7.3.2 Europe Erectile Dysfunction Revenue by Country (2017-2028) 56
7.3.3 Germany 58
7.3.4 France 58
7.3.5 U.K. 59
7.3.6 Italy 59
7.3.7 Russia 60
8 ASIA PACIFIC 61
8.1 Asia Pacific Erectile Dysfunction Market Size by Type 61
8.1.1 Asia Pacific Erectile Dysfunction Sales by Type (2017-2028) 61
8.1.2 Asia Pacific Erectile Dysfunction Revenue by Type (2017-2028) 62
8.2 Asia Pacific Erectile Dysfunction Market Size by Application 63
8.2.1 Asia Pacific Erectile Dysfunction Sales by Application (2017-2028) 63
8.2.2 Asia Pacific Erectile Dysfunction Revenue by Application (2017-2028) 64
8.3 Asia Pacific Erectile Dysfunction Market Size by Region 65
8.3.1 Asia Pacific Erectile Dysfunction Sales by Region (2017-2028) 65
8.3.2 Asia Pacific Erectile Dysfunction Revenue by Region (2017-2028) 67
8.3.3 China 69
8.3.4 Japan 69
8.3.5 South Korea 70
8.3.6 India 70
8.3.7 Australia 71
8.3.8 China Taiwan 71
8.3.9 Indonesia 72
8.3.10 Thailand 72
8.3.11 Malaysia 73
9 LATIN AMERICA 74
9.1 Latin America Erectile Dysfunction Market Size by Type 74
9.1.1 Latin America Erectile Dysfunction Sales by Type (2017-2028) 74
9.1.2 Latin America Erectile Dysfunction Revenue by Type (2017-2028) 75
9.2 Latin America Erectile Dysfunction Market Size by Application 76
9.2.1 Latin America Erectile Dysfunction Sales by Application (2017-2028) 76
9.2.2 Latin America Erectile Dysfunction Revenue by Application (2017-2028) 77
9.3 Latin America Erectile Dysfunction Market Size by Country 78
9.3.1 Latin America Erectile Dysfunction Sales by Country (2017-2028) 78
9.3.2 Latin America Erectile Dysfunction Revenue by Country (2017-2028) 79
9.3.3 Brazil 80
9.3.4 Argentina 81
10 MIDDLE EAST AND AFRICA 82
10.1 Middle East and Africa Erectile Dysfunction Market Size by Type 82
10.1.1 Middle East and Africa Erectile Dysfunction Sales by Type (2017-2028) 82
10.1.2 Middle East and Africa Erectile Dysfunction Revenue by Type (2017-2028) 83
10.2 Middle East and Africa Erectile Dysfunction Market Size by Application 84
10.2.1 Middle East and Africa Erectile Dysfunction Sales by Application (2017-2028) 84
10.2.2 Middle East and Africa Erectile Dysfunction Revenue by Application (2017-2028) 85
10.3 Middle East and Africa Erectile Dysfunction Market Size by Country 86
10.3.1 Middle East and Africa Erectile Dysfunction Sales by Country (2017-2028) 86
10.3.2 Middle East and Africa Erectile Dysfunction Revenue by Country (2017-2028) 87
10.3.3 Turkey 89
10.3.4 Saudi Arabia 89
10.3.5 UAE 90
11 CORPORATE PROFILE 91
11.1 Eli Lilly 91
11.1.1 Eli Lilly Corporation Information 91
11.1.2 Eli Lilly Overview 91
11.1.3 Eli Lilly Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 92
11.1.4 Eli Lilly Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 92
11.1.5 Eli Lilly Recent Developments 93
11.2 Pfizer 93
11.2.1 Pfizer Corporation Information 93
11.2.2 Pfizer Overview 93
11.2.3 Pfizer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 94
11.2.4 Pfizer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 94
11.2.5 Pfizer Recent Developments 95
11.3 Bayer 95
11.3.1 Bayer Corporation Information 95
11.3.2 Bayer Overview 96
11.3.3 Bayer Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 97
11.3.4 Bayer Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 97
11.3.5 Bayer Recent Developments 98
11.4 BaiYunShan General Factory 98
11.4.1 BaiYunShan General Factory Corporation Information 98
11.4.2 BaiYunShan General Factory Overview 99
11.4.3 BaiYunShan General Factory Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 100
11.4.4 BaiYunShan General Factory Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 100
11.4.5 BaiYunShan General Factory Recent Developments 101
11.5 S.K. Chemicals 101
11.5.1 S.K. Chemicals Corporation Information 101
11.5.2 S.K. Chemicals Overview 101
11.5.3 S.K. Chemicals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 102
11.5.4 S.K. Chemicals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 102
11.5.5 S.K. Chemicals Recent Developments 103
11.6 Teva Pharma 103
11.6.1 Teva Pharma Corporation Information 103
11.6.2 Teva Pharma Overview 104
11.6.3 Teva Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 104
11.6.4 Teva Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 105
11.6.5 Teva Pharma Recent Developments 105
11.7 Dong-A ST 106
11.7.1 Dong-A ST Corporation Information 106
11.7.2 Dong-A ST Overview 106
11.7.3 Dong-A ST Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 107
11.7.4 Dong-A ST Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 107
11.7.5 Dong-A ST Recent Developments 108
11.8 Petros Pharmaceuticals 108
11.8.1 Petros Pharmaceuticals Corporation Information 108
11.8.2 Petros Pharmaceuticals Overview 109
11.8.3 Petros Pharmaceuticals Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 109
11.8.4 Petros Pharmaceuticals Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 109
11.8.5 Petros Pharmaceuticals Recent Developments 110
11.9 Seoul Pharma 110
11.9.1 Seoul Pharma Corporation Information 110
11.9.2 Seoul Pharma Overview 111
11.9.3 Seoul Pharma Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 111
11.9.4 Seoul Pharma Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 111
11.9.5 Seoul Pharma Recent Developments 112
11.10 Yabang Pharmacy 113
11.10.1 Yabang Pharmacy Corporation Information 113
11.10.2 Yabang Pharmacy Overview 113
11.10.3 Yabang Pharmacy Erectile Dysfunction Sales, Price, Revenue and Gross Margin (2017-2022) 114
11.10.4 Yabang Pharmacy Erectile Dysfunction Product Model Numbers, Pictures, Descriptions and Specifications 114
11.10.5 Yabang Pharmacy Recent Developments 115
12 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS 116
12.1 Erectile Dysfunction Industry Chain Analysis 116
12.2 Erectile Dysfunction Key Raw Materials 116
12.2.1 Key Raw Materials 116
12.2.2 Raw Materials Key Suppliers 116
12.3 Erectile Dysfunction Production Mode & Process 117
12.4 Erectile Dysfunction Sales and Marketing 118
12.4.1 Erectile Dysfunction Sales Channels 118
12.4.2 Erectile Dysfunction Distributors 118
12.5 Erectile Dysfunction Customers 120
13 ERECTILE DYSFUNCTION MARKET DYNAMICS 121
13.1.1 Erectile Dysfunction Industry Trends 121
13.1.2 Erectile Dysfunction Market Drivers 121
13.1.3 Erectile Dysfunction Market Challenges 122
13.1.4 Erectile Dysfunction Market Restraints 122
14 KEY FINDINGS IN THE GLOBAL ERECTILE DYSFUNCTION STUDY 123
15 APPENDIX 124
15.1 Research Methodology 124
15.1.1 Methodology/Research Approach 124
15.1.2 Data Source 127
15.2 Author Details 129
15.3 Disclaimer 130
Access full Report Description, Table of Figure, Chart, FREE sample, etc. please click
https://us.qyresearch.com/reports/348289/erectile-dysfunction
Any doubts and questions will be welcome.
Customization of the Report:
This report can be customized to meet the client's requirements. Please contact with us (global@qyresearch.com), who will ensure that you get a report that suits your needs.
About Us:
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
Contact Us
QY Research
E-mail: global@qyresearch.com
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States
Website: https://us.qyresearch.com
QY Research released a latest market research report on the Global Erectile Dysfunction market, which is segmented by region (country), company, by Purity, and by Application. Players, stakeholders, and other participants in the global Erectile Dysfunction market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country) and by Application for the period 2017-2028.
QYResearch founded in California, USA in 2007.It is a leading global market research and consulting company. With over 15 years' experience and professional research team in various cities over the world，QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let's work closely with you and build a bold and better future.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erectile Dysfunction Market Trends, Growth Analysis, Investigation by Regions, Types, Applications and Analysis of Key Players here
News-ID: 2603749 • Views: …
More Releases from QY Research
Global and U.S. Vinylcyclohexene Dioxide Market Report, Published by QY Research …
Vinylcyclohexene Dioxide (VCHD) is a low-viscosity aliphatic diepoxide used as a reactive diluent and crosslinking agent in epoxy resins, coatings, adhesives, and electrical insulation systems. With two oxirane groups attached to a cycloaliphatic backbone, it offers excellent thermal stability, chemical resistance, and dielectric strength, making it suitable for high-performance composites and electronic encapsulation.
https://www.qyresearch.com/reports/4934028/vinylcyclohexene-dioxide
The global market for Vinylcyclohexene Dioxide is projected at USD 86 million in 2024, growing at a…
Global and U.S. Loose Bulk Density Meters Market Report, Published by QY Researc …
Loose Bulk Density Meters are specialized instruments used to measure the mass per unit volume of bulk powders and granular materials in an uncompacted state. These devices help determine flowability, packing behavior, and quality control parameters critical in industries such as pharmaceuticals, chemicals, food processing, and construction materials. Measurement methods typically involve automated funnels, weighing platforms, and volume displacement chambers to ensure reproducibility.
https://www.qyresearch.com/reports/4937970/loose-bulk-density-meters
The global Loose Bulk Density Meters market reached…
Global and U.S. Interactive Visual Presenters Market Report, Published by QY Res …
Interactive Visual Presenters, also known as document cameras or digital visualizers, are teaching and presentation tools that project real-time images of documents, 3D objects, or live demonstrations onto large displays through HDMI, USB, or wireless interfaces. Equipped with high-resolution cameras, LED lighting, zoom, and annotation functions, they are widely used in classrooms, corporate training, and hybrid learning environments.
https://www.qyresearch.com/reports/4941119/interactive-visual-presenters
The global Interactive Visual Presenters market reached USD 584 million in 2024, growing…
Commercial Three Phase Micro Inverter Market to CAGR 12,4% by 2031 Top 10 Compan …
The global commercial three phase micro inverter market is witnessing accelerated adoption as industries and commercial establishments embrace renewable energy solutions for cost efficiency, grid stability, and sustainability. Micro inverters, which convert direct current (DC) from solar panels into alternating current (AC) at the individual panel level, are increasingly being used in commercial three phase setups for enhanced efficiency, safety, and scalability. Unlike string inverters, three phase micro inverters offer…
More Releases for Erectile
Erectile Dysfunction Drugs Market Beyond the Bedroom: The Impact of Erectile Dys …
Erectile Dysfunction Drugs Market to reach over USD XX billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report By Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel (hospital pharmacies, online pharmacies, and retail pharmacies), Region, Market…
Global Erectile Dysfunction Devices Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Erectile Dysfunction Devices Market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The market is driven by the increasing prevalence of erectile dysfunction amongst young men, advancements in medical technology, growing awareness and acceptance, the aging population, and strategic collaborations.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages…
Erectile dysfunction drugs market to Surpass erectile dysfunction drugs market | …
Global Erectile Dysfunction Drugs Market size was valued at USD 2130 million in 2021 and is projected to reach USD 3250 million by 2028, growing at a CAGR of 5.4% from 2021 to 2028 according to a new report by Intellectual Market Insights Research.
Get Sample Report:https://www.intellectualmarketinsights.com/download-sample/IMI-003946
Scope of Erectile Dysfunction Drugs Market Report:
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global…
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco…
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025.
Request for Sample of This Research Report @ https://bit.ly/2NXzatD
Top Key Players:-
Bayer AG
Pfizer
Eli Lilly & Co.
Vivus, Inc.
S.K. Chemicals Co. Ltd.
Dong-A Pharmaceutical Co. Ltd
Meda Pharmaceuticals
Apricus Biosciences
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying
According to a new study published by Polaris Market Research the global erectile dysfunction…
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a…
